CHIMERIC RECEPTORS TARGETING MUC16 AND USES THEREOF

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240189426A1
SERIAL NO

18588764

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The presently disclosed subject matter provides for chimeric receptors that target MUC16 and cells comprising such chimeric receptors. The presently disclosed subject matter further provides uses of the chimeric receptors for treatment.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEMORIAL SLOAN-KETTERING CANCER CENTERNEW YORK NY

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
ABRAHIMI, Parwiz New York, US 2 1
BRENTJENS, Renier J Short Hills, US 41 159
CHEN, Nan New York, US 140 644
MERGHOUB, Taha Jersey City, US 72 265
WOLCHOK, Jedd D New York, US 28 119

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation